TBIO.jpg
Translate Bio to Participate in Upcoming Investor Conferences
12 nov. 2020 07h30 HE | Translate Bio, Inc.
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...